Home \ Antibodies \ C3b/iC3b, Human, mAb 3E7
Catalog # HM2286

C3b/iC3b, Human, mAb 3E7

Monoclonal antibody 3E7 recognizes human complement C3b/iC3b and blocks activation of the alternative pathway (AP).

Antibody 3E7 shows enhanced specificity for C3b(i) attached to a cell surface and it can bind to C3b(i)-opsonized cells in whole blood. The antibody blocks AP based on its capacity to prevent C3b deposition on the surface of a variety AP activators and also inhibits AP-promoted lysis of rabbit erythrocytes, as used in the standard AP50 test. Clone 3E7 competes with factor B and H for binding to C3b-opsonized substrates. The use of 3E7 has been shown to enhance the immunotherapeutic action of Rituximab. The Classical Pathway is not affected or enhanced by this antibody.

Read more

125.008,370.00

Please choose the quantity of items you wish to add to your cart…
Find distributor

Understanding the Complement System: The Role of C3b/iC3b in Immune Response

The complement system is integral to both innate and adaptive immune responses, capable of producing an inflammatory and protective reaction against pathogens. This system operates via three pathways of complement activation: the classical pathway, initiated by immune complexes; the lectin pathway, triggered by surface-bound mannan-binding lectin; and the alternative pathway (AP), which activates on unprotected surfaces. Each of these pathways generates a C3 convertase, a serine protease that cleaves C3, resulting in the formation of the crucial fragment C3b, a component central to understanding the C3b/iC3b dynamic.

The Dynamics of C3b and iC3b in Complement Activation

Upon activation, C3 splits into two fragments: the smaller anaphylatoxin C3a and the larger, short-lived C3b. C3b is highly reactive, binding to complement-activating particles or immune complexes. In contrast to the classical pathway, the AP is continuously active, playing a significant role in tissue damage and inflammation in autoimmune diseases and ischemia-reperfusion injury. Recent evidence suggests that inhibiting AP activation could reduce certain disease pathologies while maintaining the host defense mechanisms provided by the classical and lectin pathways.

The Clinical Implications of C3b and iC3b

C3b is a substance that can attach to the surfaces of cells. When this happens, it can mark the cells for destruction – a process known as opsonization. However, once C3b is attached to a cell, it can change into different, inactive forms. The most important of these is iC3b, followed by C3dg. This change from C3b to iC3b is very important because it helps control how active the complement system is. The complement system is a part of our immune system that helps fight diseases. By understanding how C3b changes into iC3b, scientists can find new ways to treat diseases where this part of the immune system is involved.

Not sure which C3 antibody to use?

With numerous options available, it is essential to select the right C3 antibody to ensure the success of your research. We designed a guide to assist you in making an informed decision:

Go to our C3 researcher’s guide and choose the right antibody

Application
Flow cytometry, Functional studies, Immuno fluorescence

Application Notes
mAb 3E7 blocks the alternative pathway and not the classical pathway (Ref5).

Use
The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user’s experimental setting.

Product type
Monoclonal antibodies
Amount
1 mg, 10 mg, 100 µg, 20 µg, 5 mg, 500 µg
Formulation
Quantities >500 µg will be send without preservative and carrier free. Quantities <500 µg will be send with preservative and carrier. exact formulation can be found on the datasheet.
Immunogen
C3b(i)-Sepharose
Isotype
Mouse IgG1
Species
Human
Storage and stability
Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
Precautions
For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result from the use or derivation of this product.
Disease
Infectious diseases, Nephrology

You may also like…

You may be interested in…

Calculate your ELISA data easily

With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.

Contact us